{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:51:52Z","timestamp":1794005512466,"version":"4.8.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"34","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Department of Clinical Biochemistry"},{"name":"Herlev and Gentofte Hospital"},{"DOI":"10.13039\/501100002918","name":"Copenhagen University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims\u2003<\/jats:title>\n                  <jats:p>The atherogenic potential of cholesterol in triglyceride-rich lipoproteins, also called remnant cholesterol, is being increasingly acknowledged. Elevated remnant cholesterol is associated with increased risk of myocardial infarction and ischaemic stroke. We tested the hypothesis that elevated remnant cholesterol is also associated with increased risk of peripheral artery disease (PAD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results\u2003<\/jats:title>\n                  <jats:p>We studied 106 937 individuals from the Copenhagen General Population Study recruited in 2003\u201315. During up to 15 years of follow-up, 1586 were diagnosed with PAD, 2570 with myocardial infarction, and 2762 with ischaemic stroke. We also studied 13 974 individuals from the Copenhagen City Heart Study recruited in 1976\u201378. During up to 43 years of follow-up, 1033 were diagnosed with PAD, 2236 with myocardial infarction, and 1976 with ischaemic stroke. Remnant cholesterol was calculated from a standard lipid profile. Diagnoses were from Danish nationwide health registries. In the Copenhagen General Population Study, elevated remnant cholesterol levels were associated with higher risk of PAD, up to a multivariable adjusted hazard ratio (HR) of 4.8 (95% confidence interval 3.1\u20137.5) for individuals with levels \u22651.5 mmol\/L (58 mg\/dL) vs. &amp;lt;0.5 mmol\/L (19 mg\/dL). Corresponding results were 4.2 (2.9\u20136.1) for myocardial infarction and 1.8 (1.4\u20132.5) for ischaemic stroke. In the Copenhagen City Heart Study, corresponding HRs were 4.9 (2.9\u20138.5) for PAD, 2.6 (1.8\u20133.8) for myocardial infarction, and 2.1 (1.5\u20133.1) for ischaemic stroke.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion\u2003<\/jats:title>\n                  <jats:p>Elevated remnant cholesterol is associated with a five-fold increased risk of PAD in the general population, higher than for myocardial infarction and ischaemic stroke.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab705","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T14:53:25Z","timestamp":1632754405000},"page":"3258-3269","source":"Crossref","is-referenced-by-count":220,"title":["Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-7472","authenticated-orcid":false,"given":"Benjamin Nilsson","family":"Wadstr\u00f6m","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital , Borgmester Ib Juuls Vej 1, entrance 62, DK-2730 Herlev , Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital , Borgmester Ib Juuls Vej 73 entrance 7, 4th floor, M3, Herlev DK-2730 , Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3b 33.5., Copenhagen DK-2200 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2175-8342","authenticated-orcid":false,"given":"Anders Berg","family":"Wulff","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital , Borgmester Ib Juuls Vej 1, entrance 62, DK-2730 Herlev , Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital , Borgmester Ib Juuls Vej 73 entrance 7, 4th floor, M3, Herlev DK-2730 , Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3b 33.5., Copenhagen DK-2200 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper M\u00f8nsted","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital , Borgmester Ib Juuls Vej 1, entrance 62, DK-2730 Herlev , Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital , Borgmester Ib Juuls Vej 73 entrance 7, 4th floor, M3, Herlev DK-2730 , Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3b 33.5., Copenhagen DK-2200 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorm Boje","family":"Jensen","sequence":"additional","affiliation":[{"name":"The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital , Fasanvej 57, Hovedvejen, entrance 5, Frederiksberg DK-2000 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7220","authenticated-orcid":false,"given":"B\u00f8rge Gr\u00f8nne","family":"Nordestgaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital , Borgmester Ib Juuls Vej 1, entrance 62, DK-2730 Herlev , Denmark"},{"name":"The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital , Borgmester Ib Juuls Vej 73 entrance 7, 4th floor, M3, Herlev DK-2730 , Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3b 33.5., Copenhagen DK-2200 , Denmark"},{"name":"The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital , Fasanvej 57, Hovedvejen, entrance 5, Frederiksberg DK-2000 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"2022102610292056200_ehab705-B1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"2022102610292056200_ehab705-B2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"2022102610292056200_ehab705-B3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102610292056200_ehab705-B4","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102610292056200_ehab705-B5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/clinchem\/hvaa296","article-title":"Triglyceride-rich lipoprotein remnants and cardiovascular disease","volume":"67","author":"Duran","year":"2021","journal-title":"Clin Chem"},{"key":"2022102610292056200_ehab705-B6","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Castaner","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102610292056200_ehab705-B7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.25432","article-title":"Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population","volume":"85","author":"Varbo","year":"2019","journal-title":"Ann Neurol"},{"key":"2022102610292056200_ehab705-B8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrcardio.2018.3","article-title":"Advances in lipid-lowering therapy through gene-silencing technologies","volume":"15","author":"Nordestgaard","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2022102610292056200_ehab705-B9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab293","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","author":"Varbo","year":"2021","journal-title":"Eur Heart J"},{"key":"2022102610292056200_ehab705-B10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gheart.2013.12.008","article-title":"Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010","volume":"9","author":"Sampson","year":"2014","journal-title":"Glob Heart"},{"key":"2022102610292056200_ehab705-B11","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2022102610292056200_ehab705-B12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102610292056200_ehab705-B13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102610292056200_ehab705-B14","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"2022102610292056200_ehab705-B15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2018.09.011","article-title":"Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study","volume":"206","author":"Pradhan","year":"2018","journal-title":"Am Heart J"},{"key":"2022102610292056200_ehab705-B16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejvs.2016.12.031","article-title":"Validity of peripheral arterial disease diagnoses in the Danish National Patient Registry","volume":"53","author":"Lasota","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2022102610292056200_ehab705-B17","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"2022102610292056200_ehab705-B18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2022102610292056200_ehab705-B19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"2022102610292056200_ehab705-B20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022102610292056200_ehab705-B21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/EDE.0b013e318253e418","article-title":"Proportional hazards regression in epidemiologic follow-up studies: an intuitive consideration of primary time scale","volume":"23","author":"Cologne","year":"2012","journal-title":"Epidemiology"},{"key":"2022102610292056200_ehab705-B22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/oxfordjournals.aje.a116453","article-title":"Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error","volume":"136","author":"Rosner","year":"1992","journal-title":"Am J Epidemiol"},{"key":"2022102610292056200_ehab705-B23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1373\/clinchem.2014.234146","article-title":"Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population","volume":"61","author":"Varbo","year":"2015","journal-title":"Clin Chem"},{"key":"2022102610292056200_ehab705-B24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/oxfordjournals.aje.a115715","article-title":"Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error","volume":"132","author":"Rosner","year":"1990","journal-title":"Am J Epidemiol"},{"key":"2022102610292056200_ehab705-B25","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/sim.6095","article-title":"A toolkit for measurement error correction, with a focus on nutritional epidemiology","volume":"33","author":"Keogh","year":"2014","journal-title":"Stat Med"},{"key":"2022102610292056200_ehab705-B26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"2022102610292056200_ehab705-B27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.15.4.534","article-title":"Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo","volume":"15","author":"Nordestgaard","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102610292056200_ehab705-B28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.11.3.569","article-title":"Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans","volume":"11","author":"Shaikh","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"2022102610292056200_ehab705-B29","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.jacc.2020.09.610","article-title":"VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-containing lipoproteins","volume":"76","author":"Balling","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102610292056200_ehab705-B30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","article-title":"Peripheral arterial disease: morbidity and mortality implications","volume":"114","author":"Golomb","year":"2006","journal-title":"Circulation"},{"key":"2022102610292056200_ehab705-B31","doi-asserted-by":"crossref","first-page":"8295054","DOI":"10.1155\/2019\/8295054","article-title":"Burden of coronary artery disease and peripheral artery disease: a literature review","volume":"2019","author":"Bauersachs","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"2022102610292056200_ehab705-B32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0003319707302494","article-title":"The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients","volume":"58","author":"Poredos","year":"2007","journal-title":"Angiology"},{"key":"2022102610292056200_ehab705-B33","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/hs1101.098524","article-title":"Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank","volume":"32","author":"Grau","year":"2001","journal-title":"Stroke"},{"key":"2022102610292056200_ehab705-B34","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"2022102610292056200_ehab705-B35","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102610292056200_ehab705-B36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11936-009-0016-6","article-title":"Unusual causes of intermittent claudication: popliteal artery entrapment syndrome, cystic adventitial disease, fibromuscular dysplasia, and endofibrosis","volume":"11","author":"Korngold","year":"2009","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2022102610292056200_ehab705-B37","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.118.035432","article-title":"Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence","volume":"138","author":"Aday","year":"2018","journal-title":"Circulation"},{"key":"2022102610292056200_ehab705-B38","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102610292056200_ehab705-B39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/clinchem\/hvaa290","article-title":"Very low-density lipoprotein cholesterol may mediate a substantial component of the effect of obesity on myocardial infarction risk: the Copenhagen General Population Study","volume":"67","author":"Johansen","year":"2021","journal-title":"Clin Chem"},{"key":"2022102610292056200_ehab705-B40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.atherosclerosis.2017.03.032","article-title":"Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor alpha modulator (SPPARMalpha), in combination with statin treatment: two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia","volume":"261","author":"Arai","year":"2017","journal-title":"Atherosclerosis"},{"key":"2022102610292056200_ehab705-B41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102610292056200_ehab705-B42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2022102610292056200_ehab705-B43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/CIRCULATIONAHA.121.053797","article-title":"Prioritizing the role of major lipoproteins and subfractions as risk factors for peripheral artery disease","volume":"144","author":"Levin","year":"2021","journal-title":"Circulation"},{"key":"2022102610292056200_ehab705-B44","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/ATVBAHA.120.315639","article-title":"Per-particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins: Copenhagen General Population Study","volume":"41","author":"Johansen","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102610292056200_ehab705-B45","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"J\u00f8rgensen","year":"2013","journal-title":"Eur Heart J"},{"key":"2022102610292056200_ehab705-B46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2017.279463","article-title":"Remnant cholesterol and myocardial infarction in normal weight, overweight, and obese individuals from the Copenhagen General Population Study","volume":"64","author":"Varbo","year":"2018","journal-title":"Clin Chem"},{"key":"2022102610292056200_ehab705-B47","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"2022102610292056200_ehab705-B48","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1161\/CIRCULATIONAHA.105.608679","article-title":"Risk factors for progression of peripheral arterial disease in large and small vessels","volume":"113","author":"Aboyans","year":"2006","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/34\/3258\/46642575\/ehab705.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/34\/3258\/46642575\/ehab705.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T10:46:03Z","timestamp":1666781163000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/34\/3258\/6399975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":48,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2021,10,18]]},"published-print":{"date-parts":[[2022,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab705","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,7]]},"published":{"date-parts":[[2021,10,18]]}}}